New strategies in the treatment of osteolytic bone metastasis of mammary carcinoma

Number of publications: 3
Israeli Partner: G. Golomb, Hebrew Univ.
German Partner: M. Berger, DKFZ


Elazar, V., Adwan, H., Bauerle, T., Rohekar, K., Golomb, G., Berger, M. R.

Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis 126 (7), Int J Cancer, 1749-60, 2010

Elazar, V., Adwan, H., Rohekar, K., Zepp, M., Lifshitz-Shovali, R., Berger, M. R., Golomb, G.

Biodistribution of antisense nanoparticles in mammary carcinoma rat model 17 (6), Drug Deliv, 408-18, 2010

Reufsteck, C., Lifshitz-Shovali, R., Zepp, M., Bauerle, T., Kubler, D., Golomb, G., Berger, M. R.

Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions 29 (5), Clin Exp Metastasis, 441-56, 2012

to top